Keyphrases
Healthy Volunteers
100%
Randomized Clinical Trial
100%
Microbiome
100%
Gut Microbiome
100%
Amoxicillin
100%
Trametes Versicolor
100%
Polysaccharopeptide
100%
Antibiotics
57%
Prebiotics
57%
Human Gut Microbiota
28%
Inflammatory Bowel Disease
14%
Diarrhea
14%
Pathophysiology
14%
Intestine
14%
Microflora
14%
Healthy Individuals
14%
Treatment Control
14%
Beneficial Effects
14%
Human Microbiome
14%
Treatment Effect
14%
Human Host
14%
Treatment Group
14%
Antibiotic Therapy
14%
Stool Specimen
14%
Health Benefits
14%
Active Treatment
14%
Clostridium Difficile Infection
14%
Microbial Composition
14%
Antibiotic-associated Diarrhea
14%
Escherichia-Shigella
14%
Intestinal Microbiome
14%
Microbial Ecology
14%
BTEFAP
14%
Intestinal Health
14%
Ecological Methods
14%
T. Versicolor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
100%
Randomized Clinical Trial
100%
Microbiome
100%
Amoxicillin
100%
Trametes Versicolor
100%
Antibiotics
8%
Diarrhea
8%
Pathophysiology
8%
Antibiotic Therapy
8%
Inflammatory Bowel Disease
8%
Microflora
8%
Clostridium Difficile Infection
8%
Shigella
8%
Antibiotic Associated Diarrhea
8%
Treatment Group
8%
Side Effect
8%
Immunology and Microbiology
Normal Human
100%
Gut Microbiome
100%
Trametes Versicolor
100%
Microbiome
100%
Postsynaptic Potential
33%
Intestine
11%
Microflora
11%
Human Microbiome
11%
Inflammatory Bowel Disease
11%
Shigella
11%
Peptoclostridium difficile
11%
Escherichia
11%
Infection
11%